DigitekOn April 25, 2008, Actavis Totowa LLC announced a Class I nationwide recall for the heart drug Digitek (digoxin), which the company manufacturers for Mylan Pharmaceuticals Inc. and UDL Laboratories. The recall was announced after the FDA found that Digitek tablets appeared to be double the thickness of typical tablets, and became concerned that these tablets contained twice the active ingredient. Digitek (digoxin) is a prescription drug used to treat heart failure and arrhythmia. If patients take twice the prescribed dosage of this medication, it can lead to “digoxin overdose” which can cause serious injuries and even death. Symptoms of digoxin overdose may include any of the following: nausea, vomiting, decreased appetite, diarrhea, confusion, seizures, hallucinations, light "halos" around objects, green or yellow vision, fatigue, irregular heartbeats, and abnormally fast or slow heartbeats. Bailey Perrin Bailey is aggressively representing patients who may have been injured by recalled Digitek tablets. To request a free, no obligation, legal consultation, please submit the inquiry form on this page, or call 1-866-716-8300. |